MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

trading halt, page-31

  1. 5,269 Posts.
    lightbulb Created with Sketch. 244
    No, I don't have specific information about when the blind was lifted for thiese trial results. My estimate of two weeks comes from the November 2004 release you quote. Even so, I stick by my remark.

    My guess is that the data this time doesn't suffer from the paradoxical results and experimental noise that plagued the 2004 trial results and was therefore significantly easier to evaluate and summarize. Maybe they were able to cut some time off the two week estimate. The time came from somewhere, because this sure isn't March.

    Even if the data were clear and unambiguous, if it were negative, I would not expect a rush to publish. I would expect that there would be time spent figuring out how to present the data in the least harmful way.

    If the data were negative I sure wouldn't expect to see Roland Scully on TV the next night talking about the product.

 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.